WILMINGTON, Del., July 16, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, July 29, 2025. The company’s live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Wednesday, July 30. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investo ...

Buzz without booze? Startup GABA Labs is testing an additive that it says will take nonalcoholic drinks to the next level https://t.co/1Nqj2FU5bv ...

WILMINGTON, Del., July 14, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) announced today that Karl Bostaph, senior vice president, operations will retire on October 1, 2025. Bostaph joined Hercules in 1990 which was acquired by Ashland in 2008. Over the course of his career at Ashland, Bostaph held roles in Research and Development, Quality, Engineering and Process Technology, and Manufacturing at multiple U.S. locations. He also spent a portion of his career at manufacturing facilities outside of the ...

Core Viewpoint - Innospec Inc. has published its 2024 Sustainability Report, showcasing significant progress in sustainability commitments, growth, innovation, and community engagement [1][2]. Company Overview - Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees across 22 countries, providing a wide range of specialty chemicals for various markets [3]. Sustainability Achievements - A 23% reduction in scope 1 & 2 greenhouse gas (GHG) emissions since the baseline year of 2014 [5] - Avoided CO₂e emissions of 20.8 million metric tons through the use of fuel additives, which is over 200 times Innospec's own operational emissions [5] - Completion of product carbon footprint assessments for over 90 products, enhancing insights into GHG reduction efforts [5] - US$47.8 million spent on Research & Technology, resulting in a 22% increase in total patent filings [5] - A total social value of $791,000 delivered in 2024, benefiting 210 global charities and local good causes [5] - Over $1.6 million raised and 3,889 volunteer hours contributed through the Innospec Cares program since its launch in 2016 [5] - Launch of two new social partnerships: one with International Justice Mission (IJM) to combat modern slavery in the palm industry and another with UNESCO to support Indigenous STEM education in Brazil [5] - EcoVadis Gold rating for sustainability management practices maintained for the fourth consecutive time [5] - Over 90% of employees received careers and skills training, totaling more than 19,000 hours [5].

Group 1 - Avient Corporation plans to release its second quarter 2025 earnings on August 1, 2025, before the market opens [1] - A webcast with a slide presentation will be hosted at 8:00 a.m. Eastern Time on the same day [1] - Participants in the conference call must pre-register to receive the dial-in number and personal PIN for the Q&A session [2] Group 2 - A recording of the webcast and the slide presentation will be available on the company's investor website immediately after the conference call and will remain accessible for one year [3] - Avient Corporation focuses on being an innovator of materials solutions, aiming to help customers succeed while promoting sustainability [4] - The company employs over 9,000 employees globally, leveraging their collective strength to innovate solutions that address customer challenges and capitalize on market opportunities [4]

Company Overview - JPMorgan upgraded Phibro Animal Health Corporation (PAHC) due to strong execution following its $350 million acquisition of Zoetis' medicated feed additive and water-soluble product portfolio, which includes 37 product lines sold in about 80 countries and six manufacturing sites across the U.S., Italy, and China [1] - The acquisition is expected to enhance Phibro's profitability, improve EBITDA margins, and be accretive to adjusted earnings per share [1] Financial Performance - In Q3 2025, Phibro's sales reached $347.8 million, an increase of $84.6 million, or 32% year over year, although it missed the consensus estimate of $352.40 million [3] - Adjusted earnings for the same period were 63 cents, surpassing the consensus of 52 cents [3] Guidance and Market Outlook - Phibro raised its fiscal 2025 adjusted earnings per share guidance from $1.87-$2.01 to $1.96-$2.09, compared to the consensus of $1.94 [4] - The company revised its sales guidance from $1.25 billion-$1.30 billion to $1.26 billion-$1.29 billion, against a consensus of $1.28 billion [4] - Analyst Knyazkova noted that despite a strong performance in PAHC shares this year, there remains a favorable setup for further upside to estimates and attractive valuation [4] Industry Insights - The animal health performance is expected to exceed expectations for 2025, driven by strong demand, price increases, and healthy growth across medicated feed additives, nutritional specialties, and vaccines for 2026 [2] - While growth in livestock is slower than in companion animals, the livestock sector maintains strong fundamentals, including population growth, rising meat consumption, and limited impact from economic shifts [3]

Core Viewpoint - Graphene Manufacturing Group Limited (GMG) has initiated sales of its G® Lubricant globally, targeting various markets including Australia, the UK, Europe, China, Canada, and the US, with plans for further distribution expansion [1][3][4]. Sales and Marketing Initiatives - GMG has begun direct sales and online sales for G® Lubricant, receiving formal requests for distribution in additional countries [1][3]. - The company is investing over AU$200,000 in promotional advertising in Australia, focusing on the trucking and transport industry through various media channels [6][8]. - GMG is also spending over AU$200,000 annually on online marketing campaigns targeting the truck market across platforms like Meta, Google, and LinkedIn [6][8]. Regulatory and Compliance Efforts - GMG is in the process of registering G® Lubricant with the European Chemicals Agency under the REACH regulation, which may take up to three months [4]. - The company is seeking assistance for obtaining USA EPA approval for G® Lubricant [4]. Product Development and Partnerships - GMG is exploring partnerships with large oil and gas companies and original equipment manufacturers to scale G® Lubricant [5]. - The lubricant is currently being tested in large truck fleets, with performance feedback expected in the coming months [5]. Company Overview and Objectives - GMG is an Australian clean-technology company focused on developing energy-saving and energy storage solutions using graphene [8][9]. - The company aims to de-risk and develop commercial scale-up capabilities while securing market applications for its products [9][10]. - GMG's critical business objectives include onboarding new sales team members, expanding G® Lubricant production, and managing packaging systems in line with sales growth [10].

Core Insights - Flotek Industries (FTK) specializes in customized drilling and cementing solutions that enhance performance in oil and gas well construction [1][2][3] - The company's advanced polymers and surfactants improve drilling fluid flow, solid suspension, and wellbore cleaning, providing operators with better control in various rock formations [2][10] - Flotek's cement dispersants enhance slurry flow and pumpability under high pressure, crucial for maintaining well integrity in challenging conditions [3][10] - The company also offers anti-foam chemicals that reduce unwanted foam and trapped gas, improving operational safety and equipment protection [4][10] Industry Context - ChampionX (CHX) is a key competitor in production and drilling chemistry, focusing on cementing additives and fluid loss control agents to enhance well stability [5] - Baker Hughes (BKR) provides a comprehensive range of drilling and cementing additives, leveraging digital tools for fluid performance optimization, particularly in high-volume offshore markets [6] Financial Performance - Flotek Industries' shares have increased by 56% in the first half of the year [9] - The company trades at a forward price-to-earnings ratio of approximately 22 [11] - Recent earnings estimates for Flotek have shown positive revisions, with significant increases over the past 60 days, indicating strong growth expectations [13]

Core Viewpoint - Innospec Inc. will release its second quarter 2025 earnings results on August 5, 2025, followed by an interactive conference call on August 6, 2025, at 10:00 a.m. ET [1] Company Overview - Innospec Inc. is an international specialty chemicals company with approximately 2,400 employees across 22 countries [4] - The company manufactures and supplies a wide range of specialty chemicals for various markets including Personal Care, Home Care, Agrochemical, Mining, and Industrial [4] - Innospec's Fuel Specialties business focuses on fuel additives that enhance fuel efficiency, improve engine performance, and reduce harmful emissions [4] - The Oilfield Services segment provides specialty chemicals for the oil and gas exploration and production industry [4] Conference Call Details - The public can listen to the conference call by registering in advance through an online registration link [2] - Participants will receive an email confirmation with dial-in numbers and a unique Personal PIN for joining the conference [2] - An audio webcast of the conference call will be available on the company's website, along with a slide presentation [3] - A replay of the webcast will be accessible for 30 days following the call [3]

Core Insights - Phibro Animal Health (PAHC) shares have increased by 52.8% over the past year, significantly outperforming the industry growth of 14.3% and the S&P 500's 11.7% gain, indicating strong momentum and solid fundamentals for investors [1][8] Company Overview - Phibro, based in New Jersey, provides a wide range of products for food animals, including poultry, swine, beef, dairy cattle, and aquaculture, while also manufacturing ingredients for personal care, automotive, industrial chemicals, and chemical catalysts [2] Key Growth Drivers - The surge in Phibro's share price is attributed to robust demand for its Animal Health products, with a reported 42% sales growth year over year in the Animal Health segment, driven by a 68% increase in Medicated Feed Additives (MFA) [3][8] - The acquisition of Zoetis' MFA product portfolio has expanded Phibro's offerings by adding over 37 product lines across 80 countries, enhancing its global presence [3][8] - The company has also invested in expanding vaccine manufacturing capacity, including a new facility in Brazil, which has contributed to a 1% revenue increase in the vaccine business for the third quarter of fiscal 2025 [4] Financial Performance - Phibro reported an operating profit of $33.4 million for the fiscal third quarter, marking a 67.8% increase year over year, with an operating margin expansion of 204 basis points [6] - The Mineral Nutrition business grew by 4% year over year, supported by increased sales volume and pricing, while the Performance Products segment benefited from strong demand for personal care ingredients [5] Future Outlook - Earnings per share (EPS) for fiscal 2025 and 2026 are projected to increase by 71.4% and 12.5%, reaching $2.04 and $2.29, respectively, with revenues expected to grow by 25.7% to $1.28 billion in fiscal 2025 [10]